Cargando…

Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of visual impairment in the aging population with poorly known pathogenesis and lack of effective treatment. Age and family history are the strongest AMD risk factors, and several loci were identified to contribute to AMD. Recently, also th...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasiak, Janusz, Hyttinen, Juha M. T., Szczepanska, Joanna, Pawlowska, Elzbieta, Kaarniranta, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431062/
https://www.ncbi.nlm.nih.gov/pubmed/34502084
http://dx.doi.org/10.3390/ijms22179178
_version_ 1783750849021870080
author Blasiak, Janusz
Hyttinen, Juha M. T.
Szczepanska, Joanna
Pawlowska, Elzbieta
Kaarniranta, Kai
author_facet Blasiak, Janusz
Hyttinen, Juha M. T.
Szczepanska, Joanna
Pawlowska, Elzbieta
Kaarniranta, Kai
author_sort Blasiak, Janusz
collection PubMed
description Age-related macular degeneration (AMD) is the leading cause of visual impairment in the aging population with poorly known pathogenesis and lack of effective treatment. Age and family history are the strongest AMD risk factors, and several loci were identified to contribute to AMD. Recently, also the epigenetic profile was associated with AMD, and some long non-coding RNAs (lncRNAs) were shown to involve in AMD pathogenesis. The Vax2os1/2 (ventral anterior homeobox 2 opposite strand isoform 1) lncRNAs may modulate the balance between pro- and anti-angiogenic factors in the eye contributing to wet AMD. The stress-induced dedifferentiation of retinal pigment epithelium cells can be inhibited by the ZNF503-AS1 (zinc finger protein 503 antisense RNA 2) and LINC00167 lncRNAs. Overexpression of the PWRN2 (Prader-Willi region non-protein-coding RNA 2) lncRNA aggravated RPE cells apoptosis and mitochondrial impairment induced by oxidative stress. Several other lncRNAs were reported to exert protective or detrimental effects in AMD. However, many studies are limited to an association between lncRNA and AMD in patients or model systems with bioinformatics. Therefore, further works on lncRNAs in AMD are rational, and they should be enriched with mechanistic and clinical studies to validate conclusions obtained in high-throughput in vitro research.
format Online
Article
Text
id pubmed-8431062
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84310622021-09-11 Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration Blasiak, Janusz Hyttinen, Juha M. T. Szczepanska, Joanna Pawlowska, Elzbieta Kaarniranta, Kai Int J Mol Sci Review Age-related macular degeneration (AMD) is the leading cause of visual impairment in the aging population with poorly known pathogenesis and lack of effective treatment. Age and family history are the strongest AMD risk factors, and several loci were identified to contribute to AMD. Recently, also the epigenetic profile was associated with AMD, and some long non-coding RNAs (lncRNAs) were shown to involve in AMD pathogenesis. The Vax2os1/2 (ventral anterior homeobox 2 opposite strand isoform 1) lncRNAs may modulate the balance between pro- and anti-angiogenic factors in the eye contributing to wet AMD. The stress-induced dedifferentiation of retinal pigment epithelium cells can be inhibited by the ZNF503-AS1 (zinc finger protein 503 antisense RNA 2) and LINC00167 lncRNAs. Overexpression of the PWRN2 (Prader-Willi region non-protein-coding RNA 2) lncRNA aggravated RPE cells apoptosis and mitochondrial impairment induced by oxidative stress. Several other lncRNAs were reported to exert protective or detrimental effects in AMD. However, many studies are limited to an association between lncRNA and AMD in patients or model systems with bioinformatics. Therefore, further works on lncRNAs in AMD are rational, and they should be enriched with mechanistic and clinical studies to validate conclusions obtained in high-throughput in vitro research. MDPI 2021-08-25 /pmc/articles/PMC8431062/ /pubmed/34502084 http://dx.doi.org/10.3390/ijms22179178 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Blasiak, Janusz
Hyttinen, Juha M. T.
Szczepanska, Joanna
Pawlowska, Elzbieta
Kaarniranta, Kai
Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title_full Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title_fullStr Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title_full_unstemmed Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title_short Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration
title_sort potential of long non-coding rnas in age-related macular degeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431062/
https://www.ncbi.nlm.nih.gov/pubmed/34502084
http://dx.doi.org/10.3390/ijms22179178
work_keys_str_mv AT blasiakjanusz potentialoflongnoncodingrnasinagerelatedmaculardegeneration
AT hyttinenjuhamt potentialoflongnoncodingrnasinagerelatedmaculardegeneration
AT szczepanskajoanna potentialoflongnoncodingrnasinagerelatedmaculardegeneration
AT pawlowskaelzbieta potentialoflongnoncodingrnasinagerelatedmaculardegeneration
AT kaarnirantakai potentialoflongnoncodingrnasinagerelatedmaculardegeneration